Blockchain Registration Transaction Record

Orthocell Achieves 98.6% Success Rate in Striate Dental Membrane Study

Orthocell reports 98.6% success rate in clinical study for Striate+™ dental membrane, validating its effectiveness in bone and tissue regeneration for dental implants. The results will be presented at the EAO annual meeting and contribute to the re-certification of EU market approval.

The success of Orthocell's Striate+™ membrane in the clinical study is significant for patients, dental professionals, and the company. It signifies a breakthrough in bone and tissue regeneration, offering potential for improved outcomes in dental implant procedures and reinforcing Orthocell's position in the market. The findings also contribute to the re-certification of EU market approval, ensuring the product's continued availability for patients in need of dental implant solutions.